The Raf-1 siRNAs and Raf-1 inhibitor GW5074 were used to inhibit Raf-1 activity to further observe the underlying mechanism of Gal-1 knockdown on MDR of breast cancer cells. The gene discussed is GAL; the disease is breast cancer.